Grab your coffee—here’s a hot tip: Axsome’s stock just perked up after a big analyst said their depression drug, Auvelity, could soon help folks with Alzheimer’s too. If the FDA gives the green light, Axsome could rake in even more cash, and investors are already taking notice. The stock’s up 2% and could climb higher, so if you’re into health stocks, this one’s worth a peek! #Business #Market #StockMarket